Published in Crit Care Clin on April 01, 2012
Plasma Cytochrome c as Biomarker of Traumatic Injury and Predictor of Outcome | NCT02440373
Impaired cerebral mitochondrial oxidative phosphorylation function in a rat model of ventricular fibrillation and cardiopulmonary resuscitation. Biomed Res Int (2014) 0.84
Resveratrol Improves Survival and Prolongs Life Following Hemorrhagic Shock. Mol Med (2015) 0.83
Persistently Altered Brain Mitochondrial Bioenergetics After Apparently Successful Resuscitation From Cardiac Arrest. J Am Heart Assoc (2015) 0.79
Dynamin-related protein 1 as a therapeutic target in cardiac arrest. J Mol Med (Berl) (2015) 0.79
Estrogen fails to facilitate resuscitation from ventricular fibrillation in male rats. Am J Transl Res (2015) 0.76
Glucocorticoids as an emerging pharmacologic agent for cardiopulmonary resuscitation. Cardiovasc Drugs Ther (2014) 0.75
Early Effects of Prolonged Cardiac Arrest and Ischemic Postconditioning during Cardiopulmonary Resuscitation on Cardiac and Brain Mitochondrial Function in Pigs. Resuscitation (2017) 0.75
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell (1997) 24.57
Mitochondria and apoptosis. Science (1998) 23.41
Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem (1999) 8.16
The mitochondrial permeability transition pore and its role in cell death. Biochem J (1999) 7.72
OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell (2006) 7.72
An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem (1999) 6.88
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A (2000) 5.20
Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ (2000) 4.34
Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science (2008) 4.32
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A (2001) 3.80
Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA (1990) 3.11
Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation (2003) 2.68
Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans (2006) 2.57
Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res (2003) 2.52
Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ (2004) 2.39
A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest (2003) 2.32
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A (2003) 2.28
Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol (2002) 2.27
Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci U S A (2002) 2.16
Cariporide minimizes adverse myocardial effects of epinephrine during resuscitation from ventricular fibrillation. Crit Care Med (2005) 2.15
The release of cytochrome c from mitochondria during apoptosis of NGF-deprived sympathetic neurons is a reversible event. J Cell Biol (1999) 2.12
Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci (2002) 2.05
Mitochondrial calcium transport: mechanisms and functions. Cell Calcium (2001) 2.03
Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J Biol Chem (2001) 2.00
Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res (2006) 1.89
The relevance of mitochondrial membrane topology to mitochondrial function. Biochim Biophys Acta (2005) 1.77
Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood (2001) 1.76
Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs. J Am Coll Cardiol (2006) 1.74
Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation (1999) 1.74
Ischemic contracture of the heart: "stone heart". Am J Cardiol (1972) 1.67
Mitochondrial regular arrangement in muscle cells: a "crystal-like" pattern. Am J Physiol Cell Physiol (2004) 1.66
Zoniporide preserves left ventricular compliance during ventricular fibrillation and minimizes postresuscitation myocardial dysfunction through benefits on energy metabolism. Crit Care Med (2007) 1.66
High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention. J Am Coll Cardiol (2005) 1.66
Mitochondrial control of apoptosis: the role of cytochrome c. Biochim Biophys Acta (1998) 1.65
Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol (1996) 1.65
Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: involvement of reactive oxygen species and cardiolipin. Circ Res (2003) 1.64
Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci U S A (2003) 1.64
Maximal coronary flow and the concept of coronary vascular reserve. Circulation (1984) 1.57
Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant (2004) 1.56
Erythropoietin facilitates the return of spontaneous circulation and survival in victims of out-of-hospital cardiac arrest. Resuscitation (2009) 1.54
Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation (2004) 1.52
Postresuscitation myocardial diastolic dysfunction following prolonged ventricular fibrillation and cardiopulmonary resuscitation. Crit Care Med (2008) 1.51
Expired carbon dioxide: a noninvasive monitor of cardiopulmonary resuscitation. Circulation (1988) 1.50
Calcium in cell injury and death. Annu Rev Pathol (2006) 1.48
Cariporide given during resuscitation promotes return of electrically stable and mechanically competent cardiac activity. Resuscitation (2009) 1.48
Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. Am J Physiol (1998) 1.42
The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Circ Res (1999) 1.42
Myocardial effects of repeated electrical defibrillations in the isolated fibrillating rat heart. Crit Care Med (2000) 1.41
Increased cortical cerebral blood flow with LUCAS; a new device for mechanical chest compressions compared to standard external compressions during experimental cardiopulmonary resuscitation. Resuscitation (2005) 1.41
Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol (2001) 1.40
Myocardial effects of ventricular fibrillation in the isolated rat heart. Crit Care Med (1999) 1.40
Effects of the application of erythropoietin on cerebral recovery after cardiac arrest in rats. Resuscitation (2007) 1.40
Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J Am Coll Cardiol (2005) 1.34
Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun (2003) 1.31
The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury. Biochem Soc Symp (1999) 1.30
Reversible myocardial dysfunction after cardiopulmonary resuscitation. Resuscitation (2005) 1.28
Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: role of cardiolipin. Am J Physiol Heart Circ Physiol (2004) 1.24
Temporal relationship between cytochrome c release and mitochondrial swelling during UV-induced apoptosis in living HeLa cells. J Cell Sci (2001) 1.24
Circulating levels of cytochrome c after resuscitation from cardiac arrest: a marker of mitochondrial injury and predictor of survival. Am J Physiol Heart Circ Physiol (2006) 1.22
Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts. J Biol Chem (2004) 1.20
Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1. Cardiovasc Res (2005) 1.19
VF recurrence: characteristics and patient outcome in out-of-hospital cardiac arrest. Resuscitation (2003) 1.17
Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy. Int J Cancer (2005) 1.17
Postresuscitation left ventricular systolic and diastolic dysfunction. Treatment with dobutamine. Circulation (1997) 1.16
Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion. J Cardiovasc Pharmacol (2004) 1.15
Ca2+-induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms: role of cardiolipin. J Biol Chem (2004) 1.15
Cardiac protection by mitoKATP channels is dependent on Akt translocation from cytosol to mitochondria during late preconditioning. Am J Physiol Heart Circ Physiol (2006) 1.12
Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit Care Med (1996) 1.12
Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock (2004) 1.12
Intracellular sodium accumulation during ischemia as the substrate for reperfusion injury. Circ Res (1999) 1.12
Serum deprivation induces apoptotic cell death of transformed rat retinal ganglion cells via mitochondrial signaling pathways. Invest Ophthalmol Vis Sci (2005) 1.11
Cytochrome c and tumor necrosis factor-alpha values in serum and cerebrospinal fluid of patients with influenza-associated encephalopathy. Pediatr Infect Dis J (2005) 1.11
Protein kinase C-epsilon coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection. Am J Physiol Heart Circ Physiol (2007) 1.11
Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol (2000) 1.09
Blocking Na(+)/H(+) exchange reduces [Na(+)](i) and [Ca(2+)](i) load after ischemia and improves function in intact hearts. Am J Physiol Heart Circ Physiol (2001) 1.07
The Na(+)/H(+) exchanger: a target for cardiac therapeutic intervention. Curr Drug Targets Cardiovasc Haematol Disord (2005) 1.04
Expired PCO2 as an index of coronary perfusion pressure. Am J Emerg Med (1985) 1.03
Ventricular fibrillation voltage as a monitor of the effectiveness of cardiopulmonary resuscitation. J Lab Clin Med (1994) 1.01
Firm myocardium in cardiopulmonary resuscitation. Resuscitation (1996) 1.01
Mitochondria in apoptosis of ischemic heart. FEBS Lett (2003) 1.01
Akt activation improves oxidative phosphorylation in renal proximal tubular cells following nephrotoxicant injury. Am J Physiol Renal Physiol (2007) 1.00
Limiting sarcolemmal Na+ entry during resuscitation from ventricular fibrillation prevents excess mitochondrial Ca2+ accumulation and attenuates myocardial injury. J Appl Physiol (1985) (2007) 0.98
Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide. Circulation (2001) 0.97
Preconditioning blocks cardiocyte apoptosis: role of K(ATP) channels and PKC-epsilon. Am J Physiol Heart Circ Physiol (2002) 0.97
Sodium-hydrogen exchange inhibition during ventricular fibrillation: Beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability. Circulation (2003) 0.96
Myocardial acidosis associated with CO2 production during cardiac arrest and resuscitation. Circulation (1989) 0.96
Evolution of the stone heart after prolonged cardiac arrest. Chest (2002) 0.95
Serum cytochrome c level as a prognostic indicator in patients with systemic inflammatory response syndrome. Clin Chim Acta (2004) 0.94
Mechanism of ischemic contracture in ferret hearts: relative roles of [Ca2+]i elevation and ATP depletion. Am J Physiol (1990) 0.94
The "stone heart": a challenge to the biochemist. Am J Cardiol (1972) 0.93
Prognostic predictive values of serum cytochrome c, cytokines, and other laboratory measurements in acute encephalopathy with multiple organ failure. Arch Dis Child (2006) 0.93
Cariporide enables hemodynamically more effective chest compression by leftward shift of its flow-depth relationship. Am J Physiol Heart Circ Physiol (2005) 0.92
Optimal dosing of dobutamine for treating post-resuscitation left ventricular dysfunction. Resuscitation (2004) 0.92
Recombinant human erythropoietin influences revascularization and healing in a rat model of random ischaemic flaps. Acta Derm Venereol (2002) 0.92
Intramyocardial hypercarbic acidosis during cardiac arrest and resuscitation. Crit Care Med (1993) 0.91
Early high-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest: a matched control study. Resuscitation (2007) 0.90
Targeting mitochondria for resuscitation from cardiac arrest. Crit Care Med (2008) 0.90
Limitation of infarct size by erythropoietin is associated with translocation of Akt to the mitochondria after reperfusion. Clin Exp Pharmacol Physiol (2008) 0.88
Myocardial protection by erythropoietin during resuscitation from ventricular fibrillation. Am J Ther (2007) 0.88
Zoniporide preserves left ventricular compliance during ventricular fibrillation and minimizes postresuscitation myocardial dysfunction through benefits on energy metabolism. Crit Care Med (2007) 1.66
Limiting sarcolemmal Na+ entry during resuscitation from ventricular fibrillation prevents excess mitochondrial Ca2+ accumulation and attenuates myocardial injury. J Appl Physiol (1985) (2007) 0.98
Targeting mitochondria for resuscitation from cardiac arrest. Crit Care Med (2008) 0.90
High-dose erythropoietin during cardiac resuscitation lessens postresuscitation myocardial stunning in swine. Transl Res (2013) 0.81
Clinically plausible hyperventilation does not exert adverse hemodynamic effects during CPR but markedly reduces end-tidal PCO₂. Resuscitation (2011) 0.81
Direct injection and expression in vivo of full-length cDNA of the cardiac isoform of alpha-2 macroglobulin induces cardiac hypertrophy in the rat heart. Basic Res Cardiol (2003) 0.78
Vitamin C compromises cardiac resuscitability in a rat model of ventricular fibrillation. Am J Ther (2014) 0.76
298: NHE-1 INHIBITION LESSENS ADVERSE POST-RESUSCITATION MYOCARDIAL EFFECTS CAUSED BY SEVERE ALKALEMIA. Crit Care Med (2016) 0.75
1579: PLASMA CYTOCHROME C IN TRAUMA VICTIMS MAY INVERSELY CORRELATE WITH THE PROBABILITY OF SURVIVAL. Crit Care Med (2016) 0.75
193: CYCLOSPORINE A MAY DISRUPT MITOCHONDRIAL GENE EXPRESSION IN HUMAN LEFT VENTRICULAR CARDIOMYOCYTES. Crit Care Med (2016) 0.75
Early and sustained vasopressin infusion augments the hemodynamic efficacy of restrictive fluid resuscitation and improves survival in a liver laceration model of hemorrhagic shock. J Trauma Acute Care Surg (2016) 0.75